InvestorsObserver
×
News Home

Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Higher By 12.68% This Week?

Tuesday, July 20, 2021 09:55 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Higher By 12.68% This Week?

Arcus Biosciences Inc (RCUS) is near the top in its industry group according to InvestorsObserver. RCUS gets an overall rating of 52. That means it scores higher than 52 percent of stocks. Arcus Biosciences Inc gets a 85 rank in the Biotechnology industry. Biotechnology is number 108 out of 148 industries.

Overall Score - 52
RCUS has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on RCUS!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arcus Biosciences Inc Stock Today?

Arcus Biosciences Inc (RCUS) stock is trading at $32.00 as of 9:54 AM on Tuesday, Jul 20, a gain of $2.37, or 8% from the previous closing price of $29.63. The stock has traded between $29.60 and $32.21 so far today. Volume today is below average. So far 80,173 shares have traded compared to average volume of 914,851 shares. Click Here to get the full Stock Report for Arcus Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App